Saara Merasto

798 total citations
21 papers, 647 citations indexed

About

Saara Merasto is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Saara Merasto has authored 21 papers receiving a total of 647 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cardiology and Cardiovascular Medicine and 7 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Saara Merasto's work include Hormonal Regulation and Hypertension (5 papers), Adipose Tissue and Metabolism (4 papers) and Heart Failure Treatment and Management (3 papers). Saara Merasto is often cited by papers focused on Hormonal Regulation and Hypertension (5 papers), Adipose Tissue and Metabolism (4 papers) and Heart Failure Treatment and Management (3 papers). Saara Merasto collaborates with scholars based in Finland, Germany and Italy. Saara Merasto's co-authors include Eero Mervaala, Marjut Louhelainen, Piet Finckenberg, Dominik N. Müller, Ville Kytö, Jouko Levijoki, Friedrich C. Luft, Petri Kaheinen, Essi Martonen and Heikki Vapaatalo and has published in prestigious journals such as Hypertension, American Journal Of Pathology and British Journal of Pharmacology.

In The Last Decade

Saara Merasto

21 papers receiving 630 citations

Peers

Saara Merasto
Saara Merasto
Citations per year, relative to Saara Merasto Saara Merasto (= 1×) peers Marjut Louhelainen

Countries citing papers authored by Saara Merasto

Since Specialization
Citations

This map shows the geographic impact of Saara Merasto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saara Merasto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saara Merasto more than expected).

Fields of papers citing papers by Saara Merasto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saara Merasto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saara Merasto. The network helps show where Saara Merasto may publish in the future.

Co-authorship network of co-authors of Saara Merasto

This figure shows the co-authorship network connecting the top 25 collaborators of Saara Merasto. A scholar is included among the top collaborators of Saara Merasto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saara Merasto. Saara Merasto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Storvik, Markus, Marjut Louhelainen, Saara Merasto, et al.. (2011). Effects of Levosimendan on Cardiac Gene Expression Profile and Post-Infarct Cardiac Remodelling in Diabetic Goto-Kakizaki Rats. Basic & Clinical Pharmacology & Toxicology. 109(5). 387–397. 15 indexed citations
2.
Finckenberg, Piet, Ove Eriksson, Marc Baumann, et al.. (2011). Caloric Restriction Ameliorates Angiotensin II–Induced Mitochondrial Remodeling and Cardiac Hypertrophy. Hypertension. 59(1). 76–84. 49 indexed citations
3.
Storvik, Markus, Piet Finckenberg, Saara Merasto, et al.. (2011). Skeletal Muscle Gene Expression Profile Is Modified by Dietary Protein Source and Calcium during Energy Restriction. Lifestyle Genomics. 4(1). 49–62. 9 indexed citations
4.
Biala, Agnieszka, Antti Siltanen, Jin Shi, et al.. (2010). Resveratrol induces mitochondrial biogenesis and ameliorates Ang II-induced cardiac remodeling in transgenic rats harboring human renin and angiotensinogen genes. Blood Pressure. 19(3). 196–205. 78 indexed citations
5.
Louhelainen, Marjut, Saara Merasto, Piet Finckenberg, et al.. (2010). Effects of the calcium sensitizer OR‐1896, a metabolite of levosimendan, on post‐infarct heart failure and cardiac remodelling in diabetic Goto–Kakizaki rats. British Journal of Pharmacology. 160(1). 142–152. 7 indexed citations
6.
Biala, Agnieszka, Essi Martonen, Petri Kaheinen, et al.. (2010). Levosimendan improves cardiac function and survival in rats with angiotensin II-induced hypertensive heart failure. Hypertension Research. 33(10). 1004–1011. 2 indexed citations
7.
Louhelainen, Marjut, Saara Merasto, Petri Kaheinen, et al.. (2010). Sirtuin1-p53, forkhead box O3a, p38 and post-infarct cardiac remodeling in the spontaneously diabetic Goto-Kakizaki rat. Cardiovascular Diabetology. 9(1). 5–5. 41 indexed citations
8.
Mervaala, Eero, Agnieszka Biala, Saara Merasto, et al.. (2010). Metabolomics in Angiotensin II-Induced Cardiac Hypertrophy. Hypertension. 55(2). 508–515. 38 indexed citations
9.
Louhelainen, Marjut, Saara Merasto, Ville Kytö, et al.. (2009). Oral levosimendan prevents postinfarct heart failure and cardiac remodeling in diabetic Goto-Kakizaki rats. Journal of Hypertension. 27(10). 2094–2107. 20 indexed citations
10.
Pilvi, Taru K., Markus Storvik, Marjut Louhelainen, et al.. (2008). Effect of Dietary Calcium and Dairy Proteins on the Adipose Tissue Gene Expression Profile in Diet-Induced Obesity. Lifestyle Genomics. 1(5). 240–251. 24 indexed citations
11.
Louhelainen, Marjut, Saara Merasto, Essi Martonen, et al.. (2008). Forkhead class O transcription factor 3a activation and Sirtuin1 overexpression in the hypertrophied myocardium of the diabetic Goto-Kakizaki rat. Journal of Hypertension. 26(2). 334–344. 52 indexed citations
12.
Louhelainen, Marjut, Petri Kaheinen, Hanna Leskinen, et al.. (2007). Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats. British Journal of Pharmacology. 150(7). 851–861. 63 indexed citations
13.
Louhelainen, Marjut, Saara Merasto, Piet Finckenberg, et al.. (2006). Lipoic acid supplementation prevents cyclosporine-induced hypertension and nephrotoxicity in spontaneously hypertensive rats. Journal of Hypertension. 24(5). 947–956. 33 indexed citations
14.
Louhelainen, Marjut, Petri Kaheinen, Saara Merasto, et al.. (2006). 704 Effects of levosimendan on cardiac remodeling and cardiomyocyte apoptosis in hypertensive Dahl/Rapp rats. European Journal of Heart Failure Supplements. 5(1). 161–161. 1 indexed citations
15.
Finckenberg, Piet, Saara Merasto, Marjut Louhelainen, et al.. (2005). Magnesium supplementation prevents angiotensin II-induced myocardial damage and CTGF overexpression. Journal of Hypertension. 23(2). 375–380. 14 indexed citations
16.
Merasto, Saara, et al.. (2005). High sodium intake increases vascular superoxide formation and promotes atherosclerosis in apolipoprotein E‐deficient mice. Blood Pressure. 14(6). 373–382. 34 indexed citations
17.
Cheng, Zhong Jian, Marjut Louhelainen, Piet Finckenberg, et al.. (2005). Vascular and renal effects of vasopeptidase inhibition and angiotensin-converting enzyme blockade in spontaneously diabetic Goto-Kakizaki rats. Journal of Hypertension. 23(9). 1757–1770. 21 indexed citations
18.
Helkamaa, Teemu, Piet Finckenberg, Marjut Louhelainen, et al.. (2003). Entacapone protects from angiotensin II-induced inflammation and renal injury. Journal of Hypertension. 21(12). 2353–2363. 21 indexed citations
19.
Cheng, Zhong Jian, Piet Finckenberg, Marjut Louhelainen, et al.. (2003). Cardiovascular and renal effects of cyclooxygenase inhibition in transgenic rats harboring mouse renin-2 gene (TGR[mREN2]27). European Journal of Pharmacology. 461(2-3). 159–169. 7 indexed citations
20.
Finckenberg, Piet, Kaija Inkinen, Juhani Ahonen, et al.. (2003). Angiotensin II Induces Connective Tissue Growth Factor Gene Expression via Calcineurin-Dependent Pathways. American Journal Of Pathology. 163(1). 355–366. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026